Synektik S.A. Logo

Synektik S.A.

Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a provider and integrator of innovative solutions for the medical sector, with a focus on radiology, oncology, cardiology, and neurology. The company's core operations include the manufacturing of radiopharmaceuticals, the supply and service of advanced medical equipment, and the development of specialized IT solutions. Synektik supports medical facilities with products and services used in diagnostic imaging, nuclear medicine, and surgery, aiming to implement and disseminate modern medical technologies. The company also provides comprehensive maintenance for medical devices and IT infrastructure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 08:39
Regulatory News Service
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 4 kw. 2024
Polish 1.3 MB
2025-11-18 08:39
Regulatory News Service
wybrane dane finansowe za 4 kw. 2024
Polish 204.6 KB
2025-10-28 09:40
Report Publication Announcement
Terminy publikacji raportów okresowych - Content (PL)
Polish 2.0 KB
2025-10-27 15:29
Major Shareholding Notification
Zawiadomienie
Polish 83.0 KB
2025-10-27 15:29
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmiana …
Polish 1.7 KB
2025-10-27 12:52
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-23 12:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-21 08:51
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-20 10:43
Regulatory News Service
Temat: Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - C…
Polish 1.8 KB
2025-10-14 14:39
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-10-09 09:16
Regulatory News Service
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB
2025-09-29 13:34
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.7 KB
2025-09-23 14:05
Board/Management Information
życiorys nowego Członka Zarządu
Polish 92.3 KB
2025-09-23 14:05
Board/Management Information
Powołanie nowego Członka Zarządu - Content (PL)
Polish 1.2 KB
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synektik S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NuCana plc Logo
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America
NCNA
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary
NUTEX
NutriBand Inc. Logo
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America
NTRB
Nuvalent, Inc. Logo
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America
NUVL
Nuvation Bio Inc. Logo
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America
NUVB
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan
4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland
OBSN
OCULAR THERAPEUTIX, INC Logo
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
United States of America
OCUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.